Arcturus Therapeutics Holdings Inc. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcturus Therapeutics Holdings Inc. (ARCT)
CIK: 0001768224
Period of Report: 2021-06-18

Reporting Person: FARRELL PETER C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-18	Stock Option (right to buy)	$35.09	A	15000	Acquired	2031-06-18	Common Stock (15000)	Direct

Footnotes

F1: Shares underlying the option vest monthly over a one year period from the date of grant. This grant represents the annual grant to members of the Board of Directors.